Company

Nilo Therapeutics

Biotechnology Research New York City, United States 24 employees

Employees: 24
Contacts: 4
Emails: 4
Phones: 2

LinkedIn Crunchbase

Nilo Therapeutics Overview

Headquarters: New York City, United States
Industry: Biotechnology Research
Employees: 24
Founded: 2024
Funding: 9.6M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

to modulate immune responses via activation of neural circuits. United by our passion for discovering and translating novel biology

About Nilo Therapeutics

Nilo Therapeutics is an early-stage biotech company developing groundbreaking therapies for autoimmune and inflammatory diseases. Our experienced team brings together diverse interdisciplinary expertise to modulate immune responses via activation of neural circuits. United by our passion for discovering and translating novel biology, we are dedicated to advancing human health through transformative science.

Nilo Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Nilo Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jeff Goater	Partner at the Column Group	Greater Boston, United States	Email Phone
Mia Jaffe	Data Scientist	New York, United States	Email Phone
Laurens Kruidenier	Chief Scientific Officer at Nilo Therapeutics	Somerville, Massachusetts, United States	Email
Elitsa Stoyanova	Scientist at Nilo Therapeutics	New York City Metropolitan Area, United States	Email